TY - JOUR
KW - animal subjects
KW - morally defensible research
KW - Research ethics
AU - Hope Ferdowsian
AU - Agustin Fuentes
AU - L. Syd M. Johnson
AU - Barbara J. King
AU - Jessica Pierce
AB - Important advances in biomedical and behavioral research ethics have occurred over the past few decades, many of them centered on identifying and eliminating significant harms to human subjects of research. Comprehensive attention has not been paid to the totality of harms experienced by animal subjects, although scientific and moral progress require explicit appraisal of these harms. Science is a public good and the prioritizing within, conduct of, generation of, and application of research must soundly address questions about which research is morally defensible and valuable enough to support through funding, publication, tenure, and promotion. Likewise, educational pathways of re-imagined science are critical.
BT - Cambridge Quarterly of Healthcare Ethics
DA - 2022/01
DO - 10.1017/S0963180121000487
IS - 1
LA - en
N2 - Important advances in biomedical and behavioral research ethics have occurred over the past few decades, many of them centered on identifying and eliminating significant harms to human subjects of research. Comprehensive attention has not been paid to the totality of harms experienced by animal subjects, although scientific and moral progress require explicit appraisal of these harms. Science is a public good and the prioritizing within, conduct of, generation of, and application of research must soundly address questions about which research is morally defensible and valuable enough to support through funding, publication, tenure, and promotion. Likewise, educational pathways of re-imagined science are critical.
PY - 2022
SP - 54
EP - 58
T2 - Cambridge Quarterly of Healthcare Ethics
TI - Toward an Anti-Maleficent Research Agenda
UR - https://www.cambridge.org/core/journals/cambridge-quarterly-of-healthcare-ethics/article/toward-an-antimaleficent-research-agenda/A19530167CE1D088C969A6A63DE234D6
VL - 31
Y2 - 2023-04-07
SN - 0963-1801, 1469-2147
ER -